Effects of Blood Pressure Lowering in the Acute Phase of Total Anterior Circulation Infarcts and Other Stroke Subtypes

  title={Effects of Blood Pressure Lowering in the Acute Phase of Total Anterior Circulation Infarcts and Other Stroke Subtypes},
  author={Niaz Ahmed and Nils Wahlgren},
  journal={Cerebrovascular Diseases},
  pages={235 - 243}
Background: Lowering of blood pressure (BP) in the acute phase of stroke is reported both to worsen and to improve the outcome. To investigate whether heterogeneity exists between stroke subtypes in the response to BP lowering, we analysed data from the Intravenous Nimodipine West European Stroke Trial (INWEST). Methods: INWEST enrolled acute ischaemic stroke patients within 24 h (n = 295) to the following groups: placebo (n = 100), 1 mg/h nimodipine (n = 101) or 2 mg/h nimodipine (n = 94… 

Figures and Tables from this paper

Effects of Blood Pressure–Lowering Treatment in Different Subtypes of Acute Ischemic Stroke

The results suggest that the effect of blood pressure–lowering treatment with candesartan may differ according to different types of acute ischemic stroke, but this needs to be confirmed in future trials.

Factors related to Blood Pressure Reduction during Acute Period of Ischemic Stroke

Two potential predictors of systolic and diastolic BP reduction in acute ischemic stroke patients having symptom onset within 24 hours were identified: age, sex, stroke risk factors, severity of neurologic deficits, infarct size, occlusive lesions in the main cerebral arteries, and antihypertensive medication use.

The Time Course and Determinants of Blood Pressure within the First 48 h after Ischemic Stroke

The use of mixed effects models has identified a linear SBP and DBP fall over the first 48 h after stroke, and the timing and magnitude of this fall should be accounted for in the design of future prognostic and intervention studies.

What do we (not) know about the management of blood pressure in acute stroke?

An overview of recent studies on the management of high blood pressure in the first hours and days after stroke is presented and it is suggested that voluntarily increasing blood pressure might be beneficial in a selected subgroup of patients.

Systemic Inflammation, Blood Pressure, and Stroke Outcome

The determination of C‐reactive protein, an acute‐phase inflammation marker, may help to guide the approach in the management of blood pressure in acute ischemic stroke, and this target will be useful in the development of risk prediction strategies or therapies for the treatment of stroke in humans.

Management of hypertensive emergencies in acute brain disease: evaluation of the treatment effects of intravenous nicardipine on cerebral oxygenation.

Intravenous nicardipine is effective for the treatment of hypertensive neurological emergencies and has no adverse effect on PbtO(2) during treatment of acute hypertensive emergencies.

The Challenge of Blood Pressure Management in Neurologic Emergencies

Current national guidelines recommend lowering blood pressure after stroke only if end‐organ damage is present or if systolic/diastolic blood pressures exceed 220/120 or 185/110 mm Hg in patients ineligible and in those eligible to receive thrombolytic drug therapy, respectively.

European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage

These European Stroke Organisation guidelines provide evidence-based recommendations to assist physicians in their clinical decisions regarding BP management in acute stroke and provide further recommendations on blood pressure thresholds and for specific patient subgroups.

Acute Hypertensive Response in Patients With Stroke: Pathophysiology and Management

Current concepts pertaining to treatment of the acute hypertensive response derived from recent guidelines provided by professional organizations and “best available” evidence derived from experimental and clinical studies are summarized and incorporation of these concepts into clinical practice is discussed.



Effect of intravenous nimodipine on blood pressure and outcome after acute stroke.

DBP, but not SBP, reduction was associated with neurological worsening after the intravenous administration of high-dose nimodipine after acute stroke, and these results do not confirm or exclude a neuroprotective property of nimmodipine.

Blood pressure changes in acute cerebral infarction and hemorrhage.

BP is elevated after stroke but resolves spontaneously after 7 days, and this transient elevation in BP does not appear to result solely from the stress of hospitalization.

Blood pressure and functional recovery in acute ischemic stroke.

The results suggest that complete recovery in ischemic stroke is facilitated by a moderate blood pressure reduction when brain edema develops, most likely as the result of a more adequate cerebral perfusion pressure.

Blood Pressure Course In Patients With Acute Stroke and Matched Controls

It is conchided that rCMRO2 cannot be inferred from rCBF measurements in uncontrolled human studies, and that depression of contralaterai rCM RO2 may have preceded infarction in the opposite hemisphere, a consequence of the previous influences of diseases that predispose to stroke.

Intravenous Nimodipine West European Stroke Trial (INWEST) of Nimodipine in the Treatment of Acute Ischaemic Stroke

A potential neuroprotective effect of nimodipine by preventing calcium overload in ischaemic neurons may have been outweighed by detrimental haemodynamic effects in the ischaemia area.

The clomethiazole acute stroke study (CLASS): efficacy results in 545 patients classified as total anterior circulation syndrome (TACS).

  • N. WahlgrenS. Bornhov L. Claesson
  • Medicine, Psychology
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
  • 1999

Validation of a clinical classification for subtypes of acute cerebral infarction.

Although this classification system defines subtypes of stroke with different outcomes, simple clinical measures-level of consciousness, paresis, disability, and incontinence at onset-are more powerful predictors of death or dependency at one year.

Can a Clinical Classification of Stroke Predict Complications and Treatments during Hospitalization?

The predictive value of the Oxfordshire Community Stroke Project ischemic stroke classification for acute stroke complications, therapeutic interventions and disability at discharge was investigated

Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients.

Clomethiazole had no adverse or beneficial effect on long-term outcome for all patients but produced sedation, and the hypothesis that clometHiazole is effective in patients with large strokes will be tested in a further study.